Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Neurological Sciences
Published in: Neurological Sciences 7/2022

11-04-2022 | Dystonia | Letter to the Editor

Levodopa/carbidopa intestinal gel for pain related to levodopa-induced motor complications in Parkinson’s disease

Authors: Domiziana Rinaldi, Lanfranco De Carolis, Francesco Ceriello, Edoardo Bianchini, Francesco E. Pontieri

Published in: Neurological Sciences | Issue 7/2022

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Skogar O, Lokk J (2016) Pain management in patients with Parkinson’s disease: challenges and solutions. J Multidiscip Healthc 9:469–479CrossRef
2.
Antonini A, Odin P, Pahwa R et al (2021) The long-term impact of levodopa/carbidopa intestinal gel on “off” time in patients with advanced Parkinson’s disease: a systematic review. Adv Ther 38:2854–2890CrossRef
3.
Antonini A, Stoessl AJ, Kleinman LS et al (2018) Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson’s disease: a multi-country Delphi-panel approach. Curr Med Res Opin 34:2063–2073CrossRef
4.
Thakkar S, Fung VSC, Merola A et al (2021) 24-hour levodopa-carbidopa intestinal gel: clinical experience and practical recommendations. CNS Drugs 35:137–149CrossRef
5.
Aldred J, Anca-Herschkovitsch M, Antonini A et al (2020) Application of the “5-2-1” screening criteria in advanced Parkinson’s disease: interim analysis of DUOGLOBE. Neurodegen Dis Manag 10:309–323CrossRef
Metadata
Title
Levodopa/carbidopa intestinal gel for pain related to levodopa-induced motor complications in Parkinson’s disease
Authors
Domiziana Rinaldi
Lanfranco De Carolis
Francesco Ceriello
Edoardo Bianchini
Francesco E. Pontieri
Publication date
11-04-2022
Publisher
Springer International Publishing
Published in
Neurological Sciences / Issue 7/2022
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-022-06043-6

Other articles of this Issue 7/2022

Neurological Sciences 7/2022 Go to the issue

Original Article

Inattentional blindness to DWI lesions in spontaneous intracerebral hemorrhage

Original Article

Genetic analysis and identification of novel variations in Chinese patients with pediatric epilepsy by whole-exome sequencing

Review Article

Anxiety and depression in Alzheimer’s disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline

Original Article

Knowledge and attitudes of neurologists toward epilepsy surgery: an Italian survey

Review Article

Diagnostic approach, therapeutic strategies, and surgical indications in intradural thoracic disc herniation associated with CSF leak, intracranial hypotension, and CNS superficial siderosis

Original Article

Olfactory dysfunction is associated with motor function only in tremor-dominant Parkinson’s disease